On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults 65 and older. Moderna ...

Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...

Scientists have long been fascinated by two promising classes of antibiotics that disable RNA polymerase (RNAP). They knew that these drugs could grind gene expression to a halt in several pathogens, ...

The United States is finally getting a new type of flu shot. On August 5, the Food and Drug Administration (FDA) approved the mFlusiva vaccine for adults ages 50 and up. Made by biotechnology company ...

Dr. Marc Siegel, senior medical analyst, says newly released Anthony Fauci text messages reveal he was "too dogmatic" and too ...

According to newly released text messages from Dr. Anthony Fauci during the COVID-19 pandemic, the doctor privately worried ...

RNA technology is moving beyond vaccines to enable targeted gene-editing therapies and novel treatments for complex diseases, ...

There are issues with side effects: two-thirds of recipients reported injection-site pain, against 30 percent for the ...

Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...

The Food and Drug Administration this week approved the first mRNA flu vaccine for adults 50 and older. Health experts lauded ...

Most people won’t notice anything different this flu season. Scientists, however, believe this moment could influence vaccine ...

The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva. The vaccine is ...